What is NDC 65862-705?

65862-705 is the product NDC for Ziprasidone Hydrochloride, Ziprasidone hydrochloride 80 mg/1 capsule, listed with the FDA by Aurobindo Pharma Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ziprasidone Hydrochloride?

44 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ziprasidone Hydrochloride NDC 65862-705

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-705Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0705Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65862-705-60	6586207056065862070560	60 CAPSULE in 1 BOTTLE (65862-705-60)Marketed from Dec 27, 2016
65862-705-80	6586207058065862070580	8 BLISTER PACK in 1 CARTON (65862-705-80) / 10 CAPSULE in 1 BLISTER PACK (65862-705-10)Marketed from Dec 27, 2016
65862-705-99	6586207059965862070599	1000 CAPSULE in 1 BOTTLE (65862-705-99)Marketed from Dec 27, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ziprasidone Hydrochloride
Generic name (nonproprietary): ziprasidone hydrochloride
Active ingredients: Ziprasidone hydrochloride — 80 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 65862
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204117
Marketing start: Dec 27, 2016
Listing expires: Dec 31, 2027
Identifiers: Product ID 65862-705_7f518739-d6ea-4630-b7d5-45d78499149eSPL ID 7f518739-d6ea-4630-b7d5-45d78499149eSPL set ID cc5e1c44-79e9-45d3-b1e5-b003f550c508RxCUI 313776, 313777, 313778, 314286UNII 216X081ORUUPC 0365862702609
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862070560 followed by a unit qualifier and the quantity

Package 65862-0705-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 9, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Ziprasidone capsules are indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone’s greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [see Warnings and Precautions (5.3) ] . Prolongation of the QTc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-705

What is NDC 65862-705?: 65862-705 is the product NDC for Ziprasidone Hydrochloride, Ziprasidone hydrochloride 80 mg/1 capsule, listed with the FDA by Aurobindo Pharma Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ziprasidone Hydrochloride.
What is the active ingredient?: Ziprasidone hydrochloride.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ziprasidone Hydrochloride?: 44 other product NDCs are listed under this name. See all Ziprasidone Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ziprasidone Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
ziprasidone hydrochlorideziprasidone hcl	Ziprasidone hydrochloride 80 mg/1	CapsuleOral	AvPAK	50268-814	50268-0814-12
ziprasidone hydrochlorideziprasidone hcl	Ziprasidone hydrochloride 20 mg/1	CapsuleOral	AvPAK	50268-811	50268-0811-12
ziprasidone hydrochlorideziprasidone hcl	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	AvPAK	50268-812	50268-0812-12
ziprasidone hydrochlorideziprasidone hcl	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	AvPAK	50268-813	50268-0813-12
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	BluePoint Laboratories	68001-451	68001-0451-06
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	BluePoint Laboratories	68001-452	68001-0452-06
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 80 mg/1	CapsuleOral	BluePoint Laboratories	68001-453	68001-0453-06
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 20 mg/1	CapsuleOral	BluePoint Laboratories	68001-450	68001-0450-06
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-0787	70518-0787-0070518-0787-01
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-0782	70518-0782-0170518-0782-03

All 45 Ziprasidone Hydrochloride NDCs

Other NDCs under ANDA 204117

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204117
Product	Strength	Form · route	Labeler	Product NDC
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 20 mg/1	CapsuleOral	Aurobindo Pharma Limited	65862-702
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 20 mg/1	CapsuleOral	BluePoint Laboratories	68001-450
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	BluePoint Laboratories	68001-451
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 60 mg/1	CapsuleOral	BluePoint Laboratories	68001-452
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 80 mg/1	CapsuleOral	BluePoint Laboratories	68001-453
Ziprasidone Hydrochloride	Ziprasidone hydrochloride 40 mg/1	CapsuleOral	NuCare Pharmaceuticals,Inc.	68071-3563